Intrommune Therapeutics

Intrommune Therapeutics

Biotechnology Research New York, United States 16 employees
Employees
16
Contacts
3
Emails
3
Phones
2

Intrommune Therapeutics Overview

Headquarters
New York, United States
Phone Number
Available in AeroLeads
Website
intrommune.com
Industry
Biotechnology Research
Employees
16
Founded
2015
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords

About Intrommune Therapeutics

Intrommune Therapeutics, Inc. is a biotechnology company located in New York, NY. Intrommune is developing food allergy immunotherapies that are delivered while you brush your teeth, a lifelong habit that is ingrained in most people and ensures daily use of our product. Intrommune's elegant new treatment platform for food allergies is expected to be safe, effective and convenient. Intrommune’s first product is a therapy for patients who suffer from peanut allergy. Intrommune is developing the oral mucosal immunotherapy (OMIT) platform for food allergies. It is a long-term solution for the 220 million, including 32 million people in the U.S., who suffer from this life-altering condition.

Intrommune Therapeutics Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage
Phone contacts
2
50.0% coverage

Intrommune Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Nicole Faris Medical & Scientific Affairs Consultant
View
Erick Berglund Co-founder / Chief Science Officer
Email
Miles Mclennan Principal Pharmaceutical Consultant
Email Phone
Danya Glabau Industry Assistant Professor
Email Phone

Employees by Management Level

Individual contributor 2 profiles
Executive 1 profile
Manager 1 profile
Senior / Lead 1 profile
Associate / junior 1 profile

Department Contact Coverage

Department Contacts Email Phone
Finance 1 1 0
Executive 1 1 0
Marketing 1 1 0

Compare Similar Companies to Intrommune Therapeutics